In conversation with Forbes Australia Magazine
With lots of milestones happening locally and globally, there was no shortage of topics for conversation when founder and CEO Professor Mark Kendall appeared on 4BC Weekend Breakfast with Olympia Kwitowski.
Media spotlight: Queensland Business Weekend
As we head towards the 2032 Olympics in Brisbane, we have a unique opportunity to draw on their influence to shape a uniquely Australian approach to entrepreneurship.
But what does that represent and how do we get there? They’re powerful questions founder and CEO Professor Mark Kendall had the chance to explore in a guest column he wrote for Queensland Business Weekly in The Courier-Mail.
In conversation with The Courier-Mail
As WearOptimo works towards the release of its hydration Microwearable sensor, The Courier-Mail has shared details of its Advanced Manufacturing Facility (AMF).
Life Sciences Queensland honours Professor Mark Kendall
Proud day for WearOptimo, with recognition for our founder and CEO Professor Mark Kendall at the 2024 GENE Awards run by Life Sciences Queensland.
In conversation with The Australian
WearOptimo CEO and founder Professor Mark Kendall is used to thinking globally. But his biggest dream incorporates a homegrown ambition.
In conversation with WIRED
Professor Mark Kendall’s inventions have drawn attention from some of the world’s biggest names. Think the World Health Organization, the Bill & Melinda Gates Foundation and F1 Grand Prix winner Mark Webber.
The backing of a proven sporting degree
WearOptimo is proud to count Mark Webber AO as an investor and strategic partner. The Formula 1 champion and endurance athlete came on board after meeting WearOptimo founder and CEO Professor Mark Kendall through a mutual association with luxury watch brand Rolex.
Trials attract national attention
In recognition of the start of human trials for our hydration Microwearable sensor, WearOptimo has been the subject of a special 9 News feature.
No sweat as WearOptimo and Aspen Medical reach another milestone
Healthtech innovator WearOptimo and leading healthcare provider Aspen Medical have reached another significant milestone in the commercialisation of ground-breaking microwearable hydration sensors.
Aspen Medical has shown its further confidence in WearOptimo by following up its multi-million-dollar investment with the finalisation of a Strategic Collaboration Agreement and Distribution Framework Agreement.
Clinical trials get the green light
Human trials of a microwearable sensor for the detection of dangerous dehydration levels are set to begin after the latest successful fundraising round for HealthTech firm WearOptimo. The $5 million boost will enable the company to progress its game-changing hydration monitor, through clinical trials at QUT.